" class="no-js "lang="en-US"> Johnson & Johnson - Medtech Alert
Friday, March 29, 2024
Johnson & Johnson | Pharmtech Focus

Johnson & Johnson

About Johnson & Johnson

Johnson & Johnson

Profound Change Requires Boldness.

Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years.

The combination of new technologies and your expertise enables amazing things to happen. Teams from J&J’s consumer business are creating digital tools to help people track the health of their skin. Those working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. Imagine what the rest of our team of 134,000 people at 260 companies in more than 60 countries across the world is accomplishing. We redefine what it means to be a big company in today’s world.

Social Media Community Guidelines:
http://www.jnj.com/social-media-community-guidelines

Related Story

Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D

February 14 2023

Johnson & Johnson has announced the appointment of John Reed, to the Company’s Executive Committee as […]

Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board

December 1 2022

Johnson & Johnson has announced that its Board of Directors has elected CEO, Mr. Joaquin […]

Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area

September 21 2022

Johnson & Johnson (NYSE: JNJ) (the Company) today opened its San Francisco Bay Campus, a […]

PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials

August 18 2022

The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of […]

Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

May 12 2022

Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as […]

Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus

May 10 2022

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration […]

Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors

February 16 2022

Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, […]

Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older

November 25 2021

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has approved […]

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

October 21 2021

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the U.S. Food and Drug Administration (FDA) […]

DePuy Synthes Introduces the INHANCE ™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System

August 19 2021

Today, The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes, The Orthopaedics Company […]

Ethicon's Echelon Circular Powered Stapler Associated with Major Reduction in Serious Complications Following Colorectal Surgery

August 11 2021

Ethicon, part of the Johnson & Johnson Medical Devices Companies, today announced the results of […]

MedTech Innovator Selects 20 Premier Startups for Annual Asia Pacific Accelerator

July 14 2021

MedTech Innovator, the largest accelerator of medical device companies in the world, in partnership with Asia […]

Janssen single dose Covid-19 vaccine authorised by UK medicines regulator

June 1 2021

Janssen’s single-dose COVID-19 vaccine has been authorised for use by the UK medicines regulator. The […]

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa

May 14 2021

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the World Health Organization (WHO) and […]